Skip to content

Depression: all studies

Page 633 of 1,034: studies 6,321 to 6,330 of 10,336, newest first. Back to the depression overview

Research

Editorial: Bridging the gap: an interdisciplinary perspective on ketamine in psychiatric disorders – volume II

Frontiers in Psychiatry August 30, 2024 Glenn Hartelius, Sherry-Anne Muscat, Lucie Bartova

protocols are designed to integrate and harness the full range of ketamine's intrinsic properties, ketamine therapies can realize their full potentials [3], possibly leading to improved outcomes in broader patient populations. Our first paper, "The Montreal model: An integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression," takes this path toward...

Therapeutic modulation of the kynurenine pathway in severe mental illness and comorbidities: A potential role for serotonergic psychedelics.

Progress in Neuro-Psychopharmacology and Biological Psychiatry August 30, 2024 Antonella Campanale, Antonio Inserra, Stefano Comai 18 citations

Mounting evidence points towards a crucial role of the kynurenine pathway (KP) in the altered gut-brain axis (GBA) balance in severe mental illness (SMI, namely depression, bipolar disorder, and schizophrenia) and cardiometabolic comorbidities. Preliminary evidence shows that serotonergic psychedelics and their analogues may hold therapeutic potential in addressing the altered KP in the...

DOI: 10.1016/j.pnpbp.2024.111058 (opens in new tab) Full text (opens in new tab) Gut-brain axis Kynurenine pathway Serotonergic psychedelics Severe mental illness

Psychedelic‐assisted therapy for palliative care within a home treatment setting: A case report

Clinical Case Reports August 30, 2024 Seragnoli Federico, Martignoni Geo, Martignoni Entela et al. 3 citations

Key Clinical Message This case study describes the feasibility and safety of psychedelic‐assisted therapy (PAT) as a home‐based intervention for a patient with throat cancer experiencing significant existential distress. The patient tolerated the intervention well. This case supports the feasibility and safety of PAT for patients with life‐threatening conditions in a home setting. Abstract...

DOI: 10.1002/ccr3.9305 (opens in new tab) Psychedelic therapy Home treatment Palliative care Psychedelic‐assisted therapy +4

Peduncular Hallucinosis: Clinical characteristics, etiology, and a case report

European Psychiatry August 27, 2024 J. Garde Gonzalez, A. Oliva Lozano, P. Herrero Ortega et al.

Introduction Visual hallucinations are a relatively common neurological complaint. Peduncular hallucinosis (PH) stands out as a distinct entity, characterized by complex visual hallucinations resulting from structural lesions in the brainstem or diencephalon. Objectives We aim to provide an overview of the clinical features, etiological factors, and management strategies associated with PH,...

A Randomized Clinical Trial Comparing the Effects of Mindfulness-Based and Cognitive Behavioral Therapy-Based Stress Reduction in Medical Students

European Psychiatry August 27, 2024 Aysegul Yay-Pence, Merve Coldur, Zumra Atalay et al.

Introduction Medical students face an enormous amount of stress (Dyrbye LN et al. Ann Intern Med 2008; 149: 334-41). They suffer from higher rates of depression, anxiety, and suicide compared to the general population. Despite experiencing more mental health problems, there is a lack of research exploring ways to improve their mental health. Although there are a few small sample studies...

Mindfulness possibilities in the treatment of chronic headaches

European Psychiatry August 27, 2024 Dóra Perczel-Forintos, Dorottya Sal

Introduction Headache is a very common health problem worldwide and in our country due to the increasing environmental damage and daily stress. The proportion of patients with headache in general practice is 4-5%, in neurology up to 30%. Chronic headache as a persistent stressor exhausts the body through central sensitisation, which can lead to the consolidation of maladaptive coping strategies...

Spiritual awakening. Substance abuse, dual pathology

European Psychiatry August 27, 2024 M. J. Gordillo Montaño, L. Rodriguez Rodriguez, C. Pérez Aparicio et al.

Introduction Kambó is considered an “ancestral medicine” by the indigenous tribes of the western region of the Amazon. Objectives Through this clinical case, the aim is to present the particularities of the symptoms and management of patients with consumption of not so common substances, such as Kambo or salvia divinorum, as well as the evolution that will occur in a patient with a previous...

Real-world effectiveness and safety of esketamine intranasal spray combined with treatment-as-usual in psychiatric inpatients

European Psychiatry August 27, 2024 Erhan Kavakbasi, M. Yilmaz, Ö. Bulut et al.

Introduction Esketamine intranasal spray has been approved in both the USA and EU as a novel treatment in patients with treatment-resistant major depression (TRD) and for the management of acute depressive emergencies during the course of major depressive disorder (MDD). Real-world data on the effectiveness and safety of esketamine nasal spray in clinical use are limited. Objectives To...

Psilocybin-assisted psychotherapy for existential distress: practical considerations for therapeutic application—a review

Annals of Palliative Medicine August 22, 2024 Arum Kim, Barley Halton, Akash Shah et al. 11 citations

Existential distress is commonly experienced by patients diagnosed with a life-threatening illness. This condition has been shown to adversely impact quality of life and is correlated with increased suicidal ideation and requests for hastened death. While palliative care teams are experienced in treating depression and anxiety, existential distress is a distinct clinical condition for which...

DOI: 10.21037/apm-24-35 (opens in new tab) Psilocybin Psychotherapist Existentialism Distress

Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis

BMJ August 21, 2024 Trevor Thompson, Ping-Tao Tseng, Chih-Wei Hsu et al. 24 citations

Abstract Objective To evaluate the comparative effectiveness and acceptability of oral monotherapy using psychedelics and escitalopram in patients with depressive symptoms, considering the potential for overestimated effectiveness due to unsuccessful blinding. Design Systematic review and Bayesian network meta-analysis. Data sources Medline, Cochrane Central Register of Controlled Trials,...